Home Drug Codes J Codes J9041 · BORTEZOMIB
Updated July 1st, 2026

BORTEZOMIB J Code: J9041

Injection, bortezomib, 0.1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9041, effective October 1, 2026: $2.628 per HCPCS billing unit, up 29.0% from $2.037. From CMS's final file.

?
Medicare Payment Limit ?
$2.037
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
22
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, bortezomib, 0.1 mg
HCPCS Added Date January 1, 2005
Manufacturer Multiple Manufacturers
Route of Administration Intravenous, Subcutaneous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection, Powder, Lyophilized, For Solution | Not Available

About BORTEZOMIB

Bortezomib is a medication aligned to the HCPCS J Code: J9041 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous or subcutaneous routes and manufactured by multiple companies.

According to CMS Drug Use Information: This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 22 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00143-9098-01 bortezomib Hikma Pharmaceuticals USA Inc. 35 3.5 MG
00409-1700-01 Bortezomib Hospira, Inc. 35 3.5 MG
10019-0991-01 Bortezomib Baxter Healthcare Corporation 35 3.5 MG
25021-0244-10 Bortezomib Sagent Pharmaceuticals 35 3.5 MG
43598-0426-60 Bortezomib Dr.Reddy'S Laboratories, Inc. 35 3.5 MG
•••••-••••-•• Log in to view BORTEZOMIB
BORTEZOMIB
BORTEZOMIB
Login to view 17 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

BORTEZOMIB Pricing & Reimbursement

J9041 Private Payer Reimbursement
$2.61 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

Bortezomib 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J9041 Generic Code (Multiple Manufacturers) Bortezomib Injection, bortezomib, 0.1 mg
J9046 Dr Reddy's Laboratories, Inc Bortezomib Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
J9048 Fresenius Kabi Bortezomib Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
J9049 Hospira Bortezomib Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
J9051 Fosun Pharma Bortezomib Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
J9054 Log in to view
Log in to view all 6 505(b)(2) codes

BORTEZOMIB Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 18.03%
Avg. Days to File 18.3days
Avg. Days to Pay 28.0days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9041 claims analytics on FocalPoint →
OnPoint Oncology

BORTEZOMIB CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96401 Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96409 Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96413 Login for More Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug Login for More
96415 Login for More Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) Login for More
JW / JZ modifiers apply

CMS has identified Bortezomib (J9041) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

BORTEZOMIB Medically Unlikely Edits (MUE)

The most billing units of J9041 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.1 mg.

Practitioner Office & Hospital Outpatient
35 units / day
= 3.5 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

BORTEZOMIB Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Mantle Cell Lymphoma Multiple Myeloma
Drug Class
Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Bortezomib billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for BORTEZOMIB.
Are there any available Bortezomib patient assistance programs?
BORTEZOMIB patient assistance information can be found through Multiple Manufacturers. Visit Here →
Where can I find Bortezomib prescribing information?
BORTEZOMIB prescribing information can be found at the link below: Visit Here →
Where can I find Bortezomib side effect information?
Information regarding BORTEZOMIB's side effects can be found at MedlinePlus Visit Here →
Does billing BORTEZOMIB require JZ/JW wastage modifiers?
CMS has identified BORTEZOMIB(J9041) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.